Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B

BACKGROUND AND AIMS: The impact of nonalcoholic fatty liver disease (NAFLD) on the treatment outcome of chronic hepatitis B (CHB) is undefined and deserves an in-depth investigation. METHODS: Histologically-proven CHB receiving first-line antiviral regimens as initial therapy was enrolled and groupe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Siyu, Zhang, Xiaoxiao, Jin, Huiming, Dou, Yao, Li, Lu, Yuan, Xiwei, Dong, Chen, Hou, Mengmeng, Nan, Yue-min, Shang, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647108/
https://www.ncbi.nlm.nih.gov/pubmed/36406311
http://dx.doi.org/10.14218/JCTH.2022.00066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647108/
https://www.ncbi.nlm.nih.gov/pubmed/36406311
http://dx.doi.org/10.14218/JCTH.2022.00066

Ejemplares similares